2
RESEARCH METHODOLOGY
37
5
MARKET OVERVIEW
Digital health tech and AI drive patient safety amid rising incidents and value-based care shift.
60
5.2.1.1
RISING PATIENT SAFETY INCIDENTS
5.2.1.2
INCREASING PRIORITIZATION OF PATIENT SAFETY
5.2.1.3
ESCALATING HEALTHCARE COSTS AND SHIFT TOWARD VALUE-BASED CARE MODELS
5.2.1.4
INCREASING ADOPTION OF DIGITAL HEALTH TECHNOLOGIES
5.2.2.1
HIGH IMPLEMENTATION AND MAINTENANCE COSTS
5.2.2.2
RESISTANCE TO ADOPTION AND PERCEIVED COMPLEXITY OF PATIENT SAFETY AND RISK SOFTWARE
5.2.2.3
DATA PRIVACY AND INTEROPERABILITY CHALLENGES
5.2.3.1
GROWING ADOPTION OF AI, PREDICTIVE ANALYTICS, AND AUTOMATION
5.2.3.2
INCREASING ADOPTION OF PATIENT SAFETY AND RISK SOLUTIONS INTO MEDTECH AND PHARMA SAFETY DOMAINS
5.2.3.3
INTEGRATION OF PATIENT SAFETY AND RISK SOFTWARE WITH POPULATION HEALTH AND REAL-WORLD EVIDENCE PLATFORMS
5.2.4.1
LACK OF GLOBAL STANDARDIZATION IN SAFETY REPORTING
5.2.4.2
COMPLEX INTEGRATION WITH LEGACY SYSTEMS
5.2.4.3
LIMITED AWARENESS AND UNDERREPORTING OF SAFETY EVENTS
5.3.1
MOBILE HEALTH PLATFORMS
5.3.2
CLOUD-BASED ALARM MANAGEMENT SOLUTION
5.3.3
IOT-ENABLED SOLUTIONS
5.4
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESS
5.5.1
INDICATIVE PRICING ANALYSIS, BY KEY PLAYER
5.5.2
INDICATIVE PRICING ANALYSIS, BY REGION
5.8
INVESTMENT AND FUNDING SCENARIO
5.9.1.1
AI-POWERED RISK SCORING
5.9.1.2
AUTOMATED ROOT CAUSE ANALYSIS
5.9.1.3
REAL-TIME SAFETY DASHBOARDS
5.9.1.4
MOBILE INCIDENT REPORTING APPS
5.9.2
ADJACENT TECHNOLOGIES
5.9.2.1
CLOUD SAAS PLATFORMS
5.9.3
COMPLEMENTARY TECHNOLOGIES
5.9.3.1
EHR/EMR INTEGRATION
5.9.3.2
CLAIMS AND BILLING SYSTEMS
5.9.3.3
CREDENTIALING SYSTEMS
5.10.1
PATENT PUBLICATION TREND
5.11
KEY CONFERENCES AND EVENTS, 2025–2027
5.12.1
ADOPTION OF VIRTUAL OBSERVATION SOLUTION TO REDUCE FALL RATES IN PATIENTS
5.12.2
UTILIZATION OF ENTERPRISE RISK MANAGEMENT SYSTEM FOR ENHANCED PATIENT SAFETY
5.12.3
USE OF COMPREHENSIVE HEALTHCARE RISK MANAGEMENT SOFTWARE FOR IMPROVED REGULATORY COMPLIANCE
5.13
REGULATORY LANDSCAPE
5.13.1
REGULATORY ANALYSIS
5.13.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.14
PORTER’S FIVE FORCES ANALYSIS
5.14.1
BARGAINING POWER OF SUPPLIERS
5.14.2
BARGAINING POWER OF BUYERS
5.14.3
THREAT OF NEW ENTRANTS
5.14.4
THREAT OF SUBSTITUTES
5.14.5
INTENSITY OF COMPETITIVE RIVALRY
5.15
KEY STAKEHOLDERS AND BUYING CRITERIA
5.15.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.16.2
END-USER EXPECTATIONS
5.17.1
SUBSCRIPTION LICENSING
5.17.2
MODULAR PLATFORM APPROACH
5.17.3
IMPLEMENTATION AND INTEGRATION FEES
5.17.4
VALUE-ADDED SERVICES
5.17.5
MARKETPLACE INTEGRATION AND REGIONAL PRICING
5.18
IMPACT OF AI/GEN AI ON PATIENT SAFETY AND RISK SOFTWARE MARKET
5.18.2
TOP USE CASES AND MARKET POTENTIAL
5.18.4
CASE STUDY ON AI/GENERATIVE AI IMPLEMENTATION
5.18.4.1
USE OF AI-POWERED DATA EXTRACTION PLATFORM WITH RISK MANAGEMENT SOFTWARE
5.18.5
INTERCONNECTED AND ADJACENT ECOSYSTEMS
5.18.5.1
PHARMACOVIGILANCE AND DRUG SAFETY MONITORING
5.18.5.2
HEALTHCARE INFORMATION EXCHANGE
5.18.5.3
QUALITY IMPROVEMENT SOFTWARE
5.18.6
USER READINESS AND IMPACT ASSESSMENT
5.18.6.1
HEALTHCARE PROVIDERS
5.18.6.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
5.19
IMPACT OF 2025 US TARIFF
5.19.3
PRICE IMPACT ANALYSIS
5.19.4
IMPACT ON COUNTRY/REGION
5.19.5
IMPACT ON END-USE INDUSTRIES
6
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 18 Data Tables
109
6.2
RISK & SAFETY MANAGEMENT
6.2.1
INCIDENT REPORTING SYSTEMS
6.2.1.1
NEED FOR REAL-TIME REPORTING AND AUTOMATED WORKFLOWS TO SUPPORT GROWTH
6.2.2
EVENT MANAGEMENT & ROOT CAUSE ANALYSIS SOFTWARE
6.2.2.1
ABILITY TO ANALYZE INCIDENT PATTERNS AND IMPLEMENT RISK MITIGATION TO PROMOTE GROWTH
6.2.3
PATIENT LEARNING SYSTEMS
6.2.3.1
INCREASING FOCUS ON IMPROVING PATIENT SAFETY TO FOSTER GROWTH
6.3
COMPLIANCE & GOVERNANCE
6.3.1
RISK/COMPLIANCE MONITORING AND ANALYTICS SOFTWARE
6.3.1.1
EVOLVING NEED FOR CONTINUOUS SURVEILLANCE OF ORGANIZATIONAL ACTIVITIES TO AID GROWTH
6.3.2
GOVERNANCE, RISK, AND COMPLIANCE PLATFORMS
6.3.2.1
GROWING SHIFT FROM REACTIVE COMPLIANCE MANAGEMENT TO PROACTIVE RISK PREVENTION TO BOOST MARKET
6.4
CLINICAL SAFETY CONTROLS
6.4.1
MEDICATION SAFETY & PHARMACY-LEVEL CONTROL SOFTWARE
6.4.1.1
NEED TO PREVENT MEDICATION ERRORS TO CONTRIBUTE TO GROWTH
6.4.2
INFECTION CONTROL SYSTEMS
6.4.2.1
RISE IN PROACTIVE SURVEILLANCE, RAPID INTERVENTION, AND CONTINUOUS MONITORING TO EXPEDITE GROWTH
6.5
FINANCIAL & LEGAL RISK HANDLING
6.5.1
CLAIMS MANAGEMENT SOLUTIONS
6.5.1.1
NEED TO LEVERAGE DATA-DRIVEN CLAIMS MANAGEMENT TO MINIMIZE COSTS TO FAVOR GROWTH
6.5.2
REVENUE INTEGRITY & RISK MANAGEMENT SOLUTIONS
6.5.2.1
GROWING FOCUS ON MINIMIZING FINANCIAL AND LEGAL RISKS TO PROPEL MARKET
7
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 4 Data Tables
123
7.2
ON-PREMISE DEPLOYMENT
7.2.1
HIGHER CONTROL, SECURITY, AND CUSTOMIZATION TO BOLSTER GROWTH
7.3
CLOUD-BASED DEPLOYMENT
7.3.1
NEED TO REDUCE IT OVERHEAD AND ENABLE FASTER INNOVATION TO SPUR GROWTH
7.4.1
ABILITY TO SUPPORT REAL-TIME INCIDENT REPORTING, ROOT CAUSE ANALYSIS, AND COMPLIANCE MONITORING TO DRIVE MARKET
8
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 13 Data Tables
128
8.2.1.1
RISING DEMAND FOR HIGH-QUALITY CARE AND PATIENT SAFETY TO ACCELERATE GROWTH
8.2.2.1
INCREASING DEMAND FOR QUALITY CARE IN OUTPATIENT AND AMBULATORY SETTINGS TO FACILITATE GROWTH
8.2.3
AMBULATORY CARE CENTERS
8.2.3.1
GROWING SHIFT TOWARD OUTPATIENT AND VALUE-BASED CARE MODELS TO DRIVE MARKET
8.2.4
LONG-TERM CARE CENTERS
8.2.4.1
INCREASING FOCUS ON ELDERLY CARE AND PATIENTS WITH CHRONIC CONDITIONS TO AID GROWTH
8.2.5.1
ENHANCED MEDICAL SAFETY AND REGULATORY COMPLIANCE TO AUGMENT GROWTH
8.2.6
OTHER HEALTHCARE PROVIDERS
8.3
PHARMACEUTICAL & BIOTECH COMPANIES
8.3.1
NEED TO MAINTAIN PRODUCT QUALITY, REGULATORY COMPLIANCE, AND PHARMACOVIGILANCE TO ENCOURAGE GROWTH
8.4.1
INCREASING ADOPTION OF PATIENT SAFETY AND RISK SOFTWARE FOR ENHANCED QUALITY ACROSS HEALTHCARE ECOSYSTEM TO AID GROWTH
8.5.1
GROWING RISK OF DATA INTEGRITY AND CYBERSECURITY TO FUEL MARKET
9
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY REGION
Comprehensive coverage of 9 Regions with country-level deep-dive of 17 Countries | 232 Data Tables.
140
9.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2.1
INCREASING INITIATIVES FOR IMPROVING PATIENT AND HEALTHCARE WORKFORCE SAFETY TO AID GROWTH
9.2.3.1
RISE IN PATIENT SAFETY IMPROVEMENT PROGRAMS TO CONTRIBUTE TO GROWTH
9.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2.1
TARGETED GOVERNMENT POLICIES AND PUSH TOWARD MODERNIZING HEALTHCARE DELIVERY TO PROPEL MARKET
9.3.3.1
GROWING INITIATIVES ON IMPROVING PATIENT OUTCOMES AND REDUCING MEDICAL ERRORS TO DRIVE MARKET
9.3.4.1
INCREASING USE OF INTEGRATED DIGITAL PLATFORMS IN HOSPITALS TO EXPEDITE GROWTH
9.3.5.1
FAVORABLE NATIONAL LEGISLATION AND REGIONAL HEALTHCARE POLICIES TO PROMOTE GROWTH
9.3.6.1
RISING COMMITMENT TOWARD ENHANCED HEALTHCARE QUALITY AND CULTURE OF SAFETY TO AID GROWTH
9.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2.1
INCREASING DEPLOYMENT OF CRITICAL INCIDENT REPORTING SYSTEMS AND EHR-LINKED SAFETY MODULES TO FUEL MARKET
9.4.3.1
GROWING FOCUS ON SUPPORTING ERROR REPORTING, ROOT CAUSE ANALYSIS, AND CLINICAL PROTOCOLS TO BOOST MARKET
9.4.4.1
STRONG PUBLIC-PRIVATE SECTOR INITIATIVES TO SUPPORT GROWTH
9.4.5.1
INCREASING EMPHASIS ON QUALITY IMPROVEMENT ACROSS PUBLIC AND PRIVATE HOSPITALS TO SPUR GROWTH
9.4.6.1
INNOVATION-DRIVEN HEALTHCARE ECOSYSTEM TO FACILITATE GROWTH
9.4.7
REST OF ASIA PACIFIC
9.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2.1
INCREASING FOCUS ON REDUCING ADVERSE EVENTS AND HOSPITAL-ACQUIRED INFECTIONS TO ENCOURAGE GROWTH
9.5.3.1
EXPANDING HEALTHCARE DIGITIZATION AND NATIONAL POLICIES PROMOTING PATIENT SAFETY TO DRIVE MARKET
9.5.4
REST OF LATIN AMERICA
9.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.6.2.3
REST OF GCC COUNTRIES
9.6.3.1
INCREASING AWARENESS ABOUT PATIENT SAFETY IN PUBLIC AND PRIVATE HEALTHCARE SECTORS TO BOOST MARKET
9.6.4
REST OF MIDDLE EAST & AFRICA
10
COMPETITIVE LANDSCAPE
Discover which key players dominate the patient safety software market and their winning strategies.
260
10.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET
10.3
REVENUE SHARE ANALYSIS, 2020–2024
10.4
MARKET SHARE ANALYSIS, 2024
10.5
BRAND/SOFTWARE COMPARISON
10.6
COMPANY VALUATION AND FINANCIAL METRICS
10.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.7.5
COMPANY FOOTPRINT, 2024
10.7.5.1
COMPANY FOOTPRINT
10.7.5.2
REGION FOOTPRINT
10.7.5.3
DEPLOYMENT MODE FOOTPRINT
10.7.5.4
FUNCTION FOOTPRINT
10.7.5.5
END-USER FOOTPRINT
10.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.8.1
PROGRESSIVE COMPANIES
10.8.2
RESPONSIVE COMPANIES
10.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
10.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
10.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
10.9
COMPETITIVE SCENARIO
10.9.1
SOLUTION LAUNCHES AND ENHANCEMENTS
11
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
281
11.1.1.1
BUSINESS OVERVIEW
11.1.1.2
SOLUTIONS OFFERED
11.1.1.3
RECENT DEVELOPMENTS
11.1.6
CLARITY GROUP, INC.
11.1.7
PERFORMANCE HEALTH PARTNERS
11.1.9
RISKQUAL TECHNOLOGIES, INC.
11.1.10
PRISTA CORPORATION
11.1.14
NAVEX GLOBAL, INC.
11.1.16
AMERICAN DATA NETWORK
11.1.19
RADAR HEALTHCARE INC
11.1.20
PASCAL METRICS INC.
11.2.2
LOGICMANAGER, INC.
11.2.4
HEALTHCARE GRC PTE LTD.
12.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3
CUSTOMIZATION OPTIONS
TABLE 2
PATIENT SAFETY AND RISK SOFTWARE MARKET: RISK ANALYSIS
TABLE 3
PATIENT SAFETY AND RISK SOFTWARE MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
TABLE 4
NORTH AMERICA: HEALTHCARE DATA BREACHES, 2021–2025
TABLE 5
INDICATIVE PRICING ANALYSIS OF PATIENT SAFETY AND RISK SOFTWARE, BY KEY PLAYER, 2024 (USD)
TABLE 6
PATIENT SAFETY AND RISK SOFTWARE MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 7
PATIENT SAFETY AND RISK SOFTWARE MARKET: JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES, JANUARY 2022–SEPTEMBER 2025
TABLE 8
PATIENT SAFETY AND RISK SOFTWARE MARKET: LIST OF PATENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 9
PATIENT SAFETY AND RISK SOFTWARE MARKET: KEY CONFERENCES AND EVENTS, 2025–2027
TABLE 10
REGULATORY SCENARIO IN NORTH AMERICA
TABLE 11
REGULATORY SCENARIO IN EUROPE
TABLE 12
REGULATORY SCENARIO IN ASIA PACIFIC
TABLE 13
REGULATORY SCENARIO IN MIDDLE EAST & AFRICA
TABLE 14
REGULATORY SCENARIO IN LATIN AMERICA
TABLE 15
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20
PATIENT SAFETY AND RISK SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 21
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
TABLE 22
KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 23
PATIENT SAFETY AND RISK SOFTWARE MARKET: UNMET NEEDS
TABLE 24
PATIENT SAFETY AND RISK SOFTWARE MARKET: END-USER EXPECTATIONS
TABLE 25
US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 26
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 27
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 28
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 29
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR INCIDENT REPORTING SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 30
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR EVENT MANAGEMENT & ROOT CAUSE ANALYSIS SOFTWARE, BY REGION, 2023–2030 (USD MILLION)
TABLE 31
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR PATIENT LEARNING SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 32
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 33
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY REGION, 2023–2030 (USD MILLION)
TABLE 34
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK/COMPLIANCE MONITORING & ANALYTICS SOFTWARE, BY REGION, 2023–2030 (USD MILLION)
TABLE 35
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR GOVERNANCE, RISK, AND COMPLIANCE PLATFORMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 36
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 37
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY REGION, 2023–2030 (USD MILLION)
TABLE 38
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR MEDICATION SAFETY & PHARMACY-LEVEL CONTROL SOFTWARE, BY REGION, 2023–2030 (USD MILLION)
TABLE 39
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR INFECTION CONTROL SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 40
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 41
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY REGION, 2023–2030 (USD MILLION)
TABLE 42
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLAIMS MANAGEMENT SOLUTIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 43
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR REVENUE INTEGRITY & RISK MANAGEMENT SOLUTIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 44
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 45
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR ON-PREMISE DEPLOYMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 46
PATIENT SAFETY & RISK SOFTWARE MARKET FOR CLOUD-BASED DEPLOYMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 47
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HYBRID DEPLOYMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 48
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 49
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 50
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 51
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION)
TABLE 52
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 53
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 54
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR LONG-TERM CARE CENTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 55
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR PHARMACIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 56
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 57
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 58
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 59
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR MEDTECH COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 60
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 61
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 62
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 63
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 64
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 65
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 66
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 67
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 68
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 69
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 70
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030(USD MILLION)
TABLE 71
KEY ACTIVITIES IN US PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET
TABLE 72
US: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 73
US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 74
US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 75
US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 76
US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 77
US: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 78
US: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 79
US: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 80
CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET, BY FUNCTION, 2023–2030(USD MILLION)
TABLE 81
CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030(USD MILLION)
TABLE 82
CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030(USD MILLION)
TABLE 83
CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030(USD MILLION)
TABLE 84
CANADA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030(USD MILLION)
TABLE 85
CANADA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 86
CANADA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030(USD MILLION)
TABLE 87
CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030(USD MILLION)
TABLE 88
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030(USD MILLION)
TABLE 89
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030(USD MILLION)
TABLE 90
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030(USD MILLION)
TABLE 91
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030(USD MILLION)
TABLE 92
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030(USD MILLION)
TABLE 93
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030(USD MILLION)
TABLE 94
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 95
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030(USD MILLION)
TABLE 96
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030(USD MILLION)
TABLE 97
GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030(USD MILLION)
TABLE 98
GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030(USD MILLION)
TABLE 99
GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 100
GERMANY: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 101
GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 102
GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 103
GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 104
GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 105
UK: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 106
UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 107
UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 108
UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 109
UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 110
UK: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 111
UK: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 112
UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 113
FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 114
FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 115
FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 116
FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 117
FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 118
FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 119
FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 120
FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 121
ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 122
ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 123
ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 124
ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 125
ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 126
ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 127
ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 128
ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 129
SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 130
SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 131
SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 132
SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 133
SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 134
SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 135
SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 136
SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 137
REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 138
REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 139
REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 140
REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 141
REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 142
REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 143
REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 144
REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 145
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 146
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 147
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 148
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 149
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 150
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 151
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 152
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 153
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 154
CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 155
CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 156
CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 157
CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 158
CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 159
CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 160
CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 161
CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 162
JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 163
JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 164
JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 165
JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 166
JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 167
JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 168
JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 169
JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 170
INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 171
INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 172
INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 173
INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 174
INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 175
INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 176
INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 177
INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 178
AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 179
AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 180
AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181
AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182
AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 183
AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 184
AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 185
AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 186
SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 187
SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 188
SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 189
SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 190
SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 191
SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 192
SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 193
SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 194
REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 195
REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 196
REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 197
REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198
REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199
REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 200
REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 201
REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 202
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 203
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 204
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 205
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 206
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 207
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 208
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 209
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 210
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 211
BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 212
BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 213
BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 214
BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 215
BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 216
BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 217
BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 218
BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 219
MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 220
MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 221
MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 222
MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 223
MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 224
MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 225
MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 226
MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 227
REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 228
REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 229
REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 230
REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 231
REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 232
REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 233
REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 234
REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 235
MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 236
MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 237
MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 238
MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 239
MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 240
MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 241
MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 242
MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 243
MIDDLE EAST AND AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 244
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 245
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 246
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 247
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 248
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 249
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 250
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 251
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 252
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 253
SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 254
SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 255
SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 256
SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 257
SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 258
SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 259
SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 260
SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 261
UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 262
UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 263
UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 264
UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 265
UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 266
UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 267
UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 268
UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 269
REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 270
REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 271
REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 272
REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 273
REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 274
REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 275
REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 276
REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 277
SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 278
SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 279
SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 280
SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 281
SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 282
SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 283
SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 284
SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 285
REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
TABLE 286
REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 287
REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
TABLE 288
REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 289
REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 290
REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
TABLE 291
REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 292
REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 293
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET, JANUARY 2022–SEPTEMBER 2025
TABLE 294
PATIENT SAFETY AND RISK SOFTWARE MARKET: DEGREE OF COMPETITION
TABLE 295
PATIENT SAFETY AND RISK SOFTWARE MARKET: REGION FOOTPRINT
TABLE 296
PATIENT SAFETY AND RISK SOFTWARE MARKET: DEPLOYMENT MODE FOOTPRINT
TABLE 297
PATIENT SAFETY AND RISK SOFTWARE MARKET: FUNCTION FOOTPRINT
TABLE 298
PATIENT SAFETY AND RISK SOFTWARE MARKET: END-USER FOOTPRINT
TABLE 299
PATIENT SAFETY AND RISK SOFTWARE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 300
PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 301
PATIENT SAFETY AND RISK SOFTWARE MARKET: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 302
PATIENT SAFETY AND RISK SOFTWARE MARKET: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 303
PATIENT SAFETY AND RISK SOFTWARE MARKET: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 304
RISKONNECT, INC.: COMPANY OVERVIEW
TABLE 305
RISKONNECT, INC.: SOLUTIONS OFFERED
TABLE 306
RISKONNECT, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 307
RISKONNECT, INC.: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 308
ORIGAMI RISK LLC: COMPANY OVERVIEW
TABLE 309
ORIGAMI RISK LLC: SOLUTIONS OFFERED
TABLE 310
ORIGAMI RISK LLC: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 311
RLDATIX: COMPANY OVERVIEW
TABLE 312
RLDATIX: SOLUTIONS OFFERED
TABLE 313
RLDATIX: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 314
RLDATIX: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 315
RLDATIX: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025
TABLE 316
HEALTH CATALYST: COMPANY OVERVIEW
TABLE 317
HEALTH CATALYST: SOLUTIONS OFFERED
TABLE 318
HEALTH CATALYST: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 319
HEALTH CATALYST: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 320
SYMPLR: COMPANY OVERVIEW
TABLE 321
SYMPLR: SOLUTIONS OFFERED
TABLE 322
SYMPLR: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 323
SYMPLR: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 324
CLARITY GROUP, INC.: COMPANY OVERVIEW
TABLE 325
CLARITY GROUP, INC.: SOLUTIONS OFFERED
TABLE 326
PERFORMANCE HEALTH PARTNERS: COMPANY OVERVIEW
TABLE 327
PERFORMANCE HEALTH PARTNERS: SOLUTIONS OFFERED
TABLE 328
PERFORMANCE HEALTH PARTNERS: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 329
MORCARE: COMPANY OVERVIEW
TABLE 330
MORCARE: SOLUTIONS OFFERED
TABLE 331
RISKQUAL TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 332
RISKQUAL TECHNOLOGIES, INC.: SOLUTIONS OFFERED
TABLE 333
PRISTA CORPORATION: COMPANY OVERVIEW
TABLE 334
PRISTA CORPORATION: SOLUTIONS OFFERED
TABLE 335
SAFEQUAL: COMPANY OVERVIEW
TABLE 336
SAFEQUAL: SOLUTIONS OFFERED
TABLE 337
IQVIA: COMPANY OVERVIEW
TABLE 338
IQVIA: SOLUTIONS OFFERED
TABLE 339
IQVIA: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 340
IQVIA: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 341
INOVALON: COMPANY OVERVIEW
TABLE 342
INOVALON: SOLUTIONS OFFERED
TABLE 343
INOVALON: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 344
NAVEX GLOBAL, INC.: COMPANY OVERVIEW
TABLE 345
NAVEX GLOBAL, INC.: SOLUTIONS OFFERED
TABLE 346
NAVEX GLOBAL, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 347
NAVEX GLOBAL, INC.: DEALS, JANUARY 2022–SEPTEMBER 2024
TABLE 348
NAVEX GLOBAL, INC.: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025
TABLE 349
CENSINET: COMPANY OVERVIEW
TABLE 350
CENSINET: SOLUTIONS OFFERED
TABLE 351
CENSINET: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 352
AMERICAN DATA NETWORK: COMPANY OVERVIEW
TABLE 353
AMERICAN DATA NETWORK: SOLUTIONS OFFERED
TABLE 354
ARVENTA: COMPANY OVERVIEW
TABLE 355
ARVENTA: SOLUTIONS OFFERED
TABLE 356
COMPLIANCEQUEST: COMPANY OVERVIEW
TABLE 357
COMPLIANCEQUEST: SOLUTIONS OFFERED
TABLE 358
COMPLIANCEQUEST: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 359
COMPLIANCEQUEST: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 360
RADAR HEALTHCARE INC: COMPANY OVERVIEW
TABLE 361
RADAR HEALTHCARE INC: SOLUTIONS OFFERED
TABLE 362
PASCAL METRICS INC.: COMPANY OVERVIEW
TABLE 363
PASCAL METRICS INC.: SOLUTIONS OFFERED
TABLE 364
OMNIGO: COMPANY OVERVIEW
TABLE 365
LOGICMANAGER, INC.: COMPANY OVERVIEW
TABLE 366
DEXUR: COMPANY OVERVIEW
TABLE 367
HEALTHCARE GRC PTE. LTD.: COMPANY OVERVIEW
TABLE 368
NOSOTECH INC.: COMPANY OVERVIEW
FIGURE 1
PATIENT SAFETY AND RISK SOFTWARE MARKET SEGMENTATION AND REGIONAL SCOPE
FIGURE 4
BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5
SUPPLY-SIDE MARKET ESTIMATION
FIGURE 6
PATIENT SAFETY AND RISK SOFTWARE MARKET: REVENUE ESTIMATION APPROACH
FIGURE 7
BOTTOM-UP APPROACH: END-USER SPENDING ON PATIENT SAFETY AND RISK SOFTWARE
FIGURE 8
CAGR PROJECTIONS FROM MARKET DYNAMICS, 2025–2030
FIGURE 9
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 10
TOP-DOWN APPROACH
FIGURE 11
DATA TRIANGULATION METHODOLOGY
FIGURE 12
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2025 VS. 2030 (USD MILLION)
FIGURE 13
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2025 VS. 2030 (USD MILLION)
FIGURE 14
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 15
PATIENT SAFETY AND RISK SOFTWARE MARKET: GEOGRAPHICAL SNAPSHOT
FIGURE 16
GROWING HEALTHCARE EXPENDITURE AND RISING ADOPTION OF ADVANCED TECHNOLOGIES TO DRIVE MARKET
FIGURE 17
HEALTHCARE PROVIDERS AND US LED NORTH AMERICAN MARKET IN 2024
FIGURE 18
INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 19
EMERGING MARKETS TO HAVE HIGHER GROWTH THAN DEVELOPED MARKETS DURING FORECAST PERIOD
FIGURE 20
PATIENT SAFETY AND RISK SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 21
REPORTS SUBMITTED TO PENNSYLVANIA'S PATIENT SAFETY REPORTING SYSTEM BY HOSPITALS, 2022–2024
FIGURE 22
REPORTS SUBMITTED TO PENNSYLVANIA'S PATIENT SAFETY REPORTING SYSTEM BY NON-HOSPITALS, 2022–2024
FIGURE 23
REVENUE SHIFT IN PATIENT SAFETY AND RISK SOFTWARE MARKET
FIGURE 24
PATIENT SAFETY AND RISK SOFTWARE MARKET: VALUE CHAIN ANALYSIS
FIGURE 25
PATIENT SAFETY AND RISK SOFTWARE MARKET: ECOSYSTEM ANALYSIS
FIGURE 26
PATIENT SAFETY AND RISK SOFTWARE MARKET: INVESTMENT AND FUNDING SCENARIO
FIGURE 27
PATIENT SAFETY AND RISK SOFTWARE MARKET: JURISDICTION AND TOP APPLICANT ANALYSIS, JANUARY 2022–SEPTEMBER 2025
FIGURE 28
PATIENT SAFETY AND RISK SOFTWARE MARKET: PATENT ANALYSIS, JANUARY 2015–SEPTEMBER 2025
FIGURE 29
PATIENT SAFETY AND RISK SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 30
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS
FIGURE 31
KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 32
MARKET POTENTIAL OF AI/GENERATIVE AI IN PATIENT SAFETY AND RISK SOFTWARE
FIGURE 33
IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
FIGURE 34
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET SNAPSHOT
FIGURE 35
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET SNAPSHOT
FIGURE 36
REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET, 2020–2024 (USD MILLION)
FIGURE 37
MARKET SHARE ANALYSIS OF KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET, 2024
FIGURE 38
PATIENT SAFETY AND RISK SOFTWARE MARKET: BRAND/SOFTWARE COMPARISON
FIGURE 39
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 40
EV/EBITDA OF KEY VENDORS
FIGURE 41
PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 42
PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPANY FOOTPRINT
FIGURE 43
PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 44
HEALTH CATALYST: COMPANY SNAPSHOT (2024)
FIGURE 45
IQVIA: COMPANY SNAPSHOT (2024)
Growth opportunities and latent adjacency in Patient Safety and Risk Software Market